Compounds > n(6),n(6)-dimethyladenine

n(6),n(6)-dimethyladenine and pyrazolanthrone

n(6),n(6)-dimethyladenine has been researched along with pyrazolanthrone in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1
Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB1
Arner, P; Degerman, E; Göransson, O; Nilsson, R; Rydén, M1

Other Studies

3 other study(ies) available for n(6),n(6)-dimethyladenine and pyrazolanthrone

ArticleYear
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007
Navigating the kinome.
    Nature chemical biology, 2011, Volume: 7, Issue:4

    Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology

2011
Dimethylaminopurine inhibits metabolic effects of insulin in primary adipocytes.
    The Journal of nutritional biochemistry, 2004, Volume: 15, Issue:5

    Topics: Adenine; Adipocytes; Animals; Anthracenes; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Glucose; Insulin; JNK Mitogen-Activated Protein Kinases; Lipids; Lipolysis; Male; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, Insulin; Signal Transduction; Tyrosine

2004